Patient compliance based on genetic medicine: a literature review

[1]  G. Abdulrahman,et al.  Epidemiology of Breast Cancer in Europe and Africa , 2012, Journal of cancer epidemiology.

[2]  G. Doblhammer,et al.  [Life years gained. Long-term trends in mortality by causes of death in Germany and in an international perspective]. , 2012, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

[3]  Richard J. K. Taylor,et al.  Breast cancer risk factors in Queensland women attending population-based mammography screening. , 2012, Maturitas.

[4]  A. Stiggelbout,et al.  Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not. , 2012, Patient education and counseling.

[5]  N. Schork,et al.  Direct-to-consumer personalized genomic testing. , 2011, Human molecular genetics.

[6]  Kenneth Offit,et al.  Personalized medicine: new genomics, old lessons , 2011, Human Genetics.

[7]  T. Marteau,et al.  Impact of communicating personalized genetic risk information on perceived control over the risk: A systematic review , 2011, Genetics in Medicine.

[8]  N. Schork,et al.  Effect of direct-to-consumer genomewide profiling to assess disease risk. , 2011, The New England journal of medicine.

[9]  Edwin Cuppen,et al.  Disclosure of individual genetic data to research participants: the debate reconsidered. , 2011, Trends in genetics : TIG.

[10]  R. van Hillegersberg,et al.  Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: Design of a multicenter randomized clinical trial , 2011, BMC Cancer.

[11]  T. Marteau,et al.  Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. , 2010, The Cochrane database of systematic reviews.

[12]  S. Gruber,et al.  Prevalence and Predictors of Appropriate Colorectal Cancer Surveillance in Lynch Syndrome , 2010, The American Journal of Gastroenterology.

[13]  Salma K. Marani,et al.  Health and lifestyle behaviors among persons at risk of Lynch syndrome , 2010, Cancer Causes & Control.

[14]  C. Rotimi,et al.  Tailoring the process of informed consent in genetic and genomic research , 2010, Genome Medicine.

[15]  L. Koehly,et al.  The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? , 2010, Annual review of public health.

[16]  Jun Liu,et al.  Patient, Physician, and Payment Predictors of Statin Adherence , 2010, Medical care.

[17]  Brigitte Schlegelberger,et al.  Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2) , 2010, European Journal of Human Genetics.

[18]  E. Ingelsson,et al.  Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men , 2010, Circulation.

[19]  D. Hogarth,et al.  Smoking cessation: the potential role of risk assessment tools as motivational triggers , 2010, Postgraduate Medical Journal.

[20]  Alessandro Filippi,et al.  Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients , 2009, Circulation.

[21]  Anne L. Ersig,et al.  Communication, encouragement, and cancer screening in families with and without mutations for hereditary nonpolyposis colorectal cancer: A pilot study , 2009, Genetics in Medicine.

[22]  A. Smit,et al.  Preventing weight gain: one-year results of a randomized lifestyle intervention. , 2009, American journal of preventive medicine.

[23]  Anne L. Ersig,et al.  Colon cancer screening practices and disclosure after receipt of positive or inconclusive genetic test results for hereditary nonpolyposis colorectal cancer , 2009, Cancer.

[24]  G. Bepler,et al.  Responses to Online GSTM1 Genetic Test Results among Smokers Related to Patients with Lung Cancer: A Pilot Study , 2009, Cancer Epidemiology Biomarkers & Prevention.

[25]  S. Michie,et al.  Psychological and Behavioral Responses to Genetic Test Results Indicating Increased Risk of Obesity: Does the Causal Pathway from Gene to Obesity Matter? , 2009, Public Health Genomics.

[26]  D. Katz,et al.  Health beliefs toward cardiovascular risk reduction in patients admitted to chest pain observation units. , 2009, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[27]  G. Hortobagyi,et al.  Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation , 2009, Cancer.

[28]  Wylie Burke,et al.  Does genomic risk information motivate people to change their behavior? , 2009, Genome Medicine.

[29]  A. Mokdad,et al.  Weight control behaviors in overweight/obese U.S. adults with diagnosed hypertension and diabetes , 2009, Cardiovascular diabetology.

[30]  J. Ray,et al.  Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing. , 2009, Oncology nursing forum.

[31]  Michael Weber,et al.  The emotional impact of genetic testing and aspects of counseling prior to prescription of oral contraceptives. , 2008, Contraception.

[32]  A. Chagas,et al.  Metabolic Syndrome Patient Compliance with Drug Treatment , 2008, Clinics.

[33]  H. Valdimarsdottir,et al.  Changes in Diet and Physical Activity Following BRCA1/2 Testing , 2008, Journal of psychosocial oncology.

[34]  J. Wardle,et al.  Psychological and Behavioural Impact of Genetic Testing Smokers for Lung Cancer Risk , 2008, Journal of health psychology.

[35]  W. Foulkes,et al.  Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation , 2008, Clinical genetics.

[36]  M. Hankins,et al.  The impact of genetic testing for Crohn's disease, risk magnitude and graphical format on motivation to stop smoking: an experimental analogue study , 2008, Clinical genetics.

[37]  K. Chan,et al.  Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions , 2008, Pharmacotherapy.

[38]  T. Rebbeck,et al.  Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  R. Williamson,et al.  Asymptomatic individuals at genetic risk of haemochromatosis take appropriate steps to prevent disease related to iron overload , 2008, Liver international : official journal of the International Association for the Study of the Liver.

[40]  C. I. Neutel,et al.  Changes in lifestyle after hypertension diagnosis in Canada. , 2008, The Canadian journal of cardiology.

[41]  P. Wells,et al.  Cognitive and Behavioural Effects of Genetic Testing for Thrombophilia , 2008, Journal of Genetic Counseling.

[42]  S. Steinberg,et al.  Perceptions of cancer risks and predictors of colon and endometrial cancer screening in women undergoing genetic testing for Lynch syndrome. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Mugur V. Geana,et al.  Improving rates for screening colonoscopy: Analysis of the health information national trends survey (HINTS I) data , 2008, Surgical Endoscopy.

[44]  Muin J. Khoury,et al.  Letting the genome out of the bottle--will we get our wish? , 2008, The New England journal of medicine.

[45]  Anthony J Alberg,et al.  Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[46]  J. Hasford,et al.  Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study , 2007, European Journal of Clinical Pharmacology.

[47]  J. Cornuz,et al.  Effectiveness of biomedical risk assessment as an aid for smoking cessation: a systematic review , 2007, Tobacco Control.

[48]  S. Michie,et al.  Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking , 2007, Clinical genetics.

[49]  O. Ukoumunne,et al.  The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing , 2007, Genetics in Medicine.

[50]  R. Eeles,et al.  Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up , 2007, British Journal of Cancer.

[51]  V. Venne,et al.  Colorectal Cancer Surveillance Behaviors Among Members of Typical and Attenuated FAP Families , 2007, The American Journal of Gastroenterology.

[52]  W. Burke,et al.  Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations. , 2006, JAMA.

[53]  J. Struewing,et al.  BRCA1/2 testing in hereditary breast and ovarian cancer families III: Risk perception and screening , 2006, American journal of medical genetics. Part A.

[54]  J. Hopper,et al.  Risk‐reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study , 2006, Clinical genetics.

[55]  P. R. Ricci Bitti,et al.  Psychological impact of testing for thrombophilic alterations , 2006, Thrombosis and Haemostasis.

[56]  Ken R. Smith,et al.  Risk Reduction Behaviors and Provider Communication Following Genetic Counseling and BRCA1 Mutation Testing in an African American Kindred , 2006, Journal of Genetic Counseling.

[57]  Dudding,et al.  Screening behavior in women at increased familial risk for breast cancer , 2006, Familial Cancer.

[58]  Thomas A Burke,et al.  Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice , 2006, Journal of hypertension.

[59]  S. Narod,et al.  Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. , 2006, Cancer genetics and cytogenetics.

[60]  J. Kirk,et al.  Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer. , 2006, European journal of cancer.

[61]  T. Marteau,et al.  Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. , 2006, Social science & medicine.

[62]  K. Emmons,et al.  Complementary Medicine Use before and 1 Year Following Genetic Testing for BRCA1/2 Mutations , 2006, Cancer Epidemiology Biomarkers & Prevention.

[63]  S. Loader,et al.  Impact of genetic counseling and DNA testing on individuals with colorectal cancer with a positive family history: a population-based study. , 2005, Genetic testing.

[64]  A. Stolier,et al.  Newly Diagnosed Breast Cancer Patients Choose Bilateral Mastectomy over Breast-Conserving Surgery When Testing Positive for a BRCA1/2 Mutation , 2005, The American surgeon.

[65]  H. Meijers-Heijboer,et al.  Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures , 2005, Familial Cancer.

[66]  A. de Boer,et al.  Rate and determinants of 10-year persistence with antihypertensive drugs , 2005, Journal of hypertension.

[67]  E. Legius,et al.  Predictive Genetic Testing for Hereditary Breast and Ovarian Cancer: Psychological Distress and Illness Representations 1 Year Following Disclosure , 2005, Journal of Genetic Counseling.

[68]  J. Wardle,et al.  Will Genetic Testing for Complex Diseases Increase Motivation to Quit Smoking? Anticipated Reactions in a Survey of Smokers , 2005, Health education & behavior : the official publication of the Society for Public Health Education.

[69]  E. Legius,et al.  Surveillance Behavior and Prophylactic Surgery After Predictive Testing for Hereditary Breast/Ovarian Cancer , 2005, Behavioral medicine.

[70]  B. Meiser,et al.  Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma , 2005, Cancer.

[71]  D. Frosch,et al.  Behavioral Consequences of Testing for Obesity Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[72]  E. Thomson,et al.  Hemochromatosis and iron-overload screening in a racially diverse population. , 2005, The New England journal of medicine.

[73]  K. Devriendt,et al.  Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at one year post-test. , 2005, Genetic testing.

[74]  W. Otten,et al.  What’s the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer , 2005, Genetics in Medicine.

[75]  N. Aaronson,et al.  Screening behavior of individuals at high risk for colorectal cancer. , 2005, Gastroenterology.

[76]  R. Eeles,et al.  Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort , 2004, British Journal of Cancer.

[77]  A. Rustgi,et al.  Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. , 2004, Archives of internal medicine.

[78]  S. Loader,et al.  Impact of genetic testing for breast-ovarian cancer susceptibility. , 2004, Genetic testing.

[79]  C. Magnant,et al.  Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  A. Viel,et al.  Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer , 2004, British Journal of Cancer.

[81]  H. Lynch,et al.  Screening adherence in BRCA1/2 families is associated with primary physicians' behavior , 2004, American journal of medical genetics. Part A.

[82]  C. Isaacs,et al.  Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  N. Leslie,et al.  Knowledge and educational needs of individuals with the factor V Leiden mutation , 2003, Journal of thrombosis and haemostasis : JTH.

[84]  D. Tucker,et al.  Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis , 2003, American Journal of Gastroenterology.

[85]  B. Dahlbäck,et al.  Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women , 2003, Acta obstetricia et gynecologica Scandinavica.

[86]  J. Klijn,et al.  Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  R. Croyle,et al.  Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing , 2003, American journal of medical genetics. Part A.

[88]  L. Pilote,et al.  Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. , 2003, American heart journal.

[89]  G. Petersen,et al.  Impact of genetic counseling and testing on colorectal cancer screening behavior. , 2002, Genetic testing.

[90]  Muhammad Mamdani,et al.  Adherence with statin therapy in elderly patients with and without acute coronary syndromes. , 2002, JAMA.

[91]  C. Isaacs,et al.  Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[92]  M. Weinstein,et al.  Long-term persistence in use of statin therapy in elderly patients. , 2002, JAMA.

[93]  Colleen M McBride,et al.  Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[94]  J. Satagopan,et al.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. , 2002, The New England journal of medicine.

[95]  J. Klijn,et al.  One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery) , 2002, Breast Cancer Research and Treatment.

[96]  B. Meiser,et al.  What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. , 2002, Social science & medicine.

[97]  J. Satagopan,et al.  Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[98]  A. Shuldiner,et al.  Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation. , 2001, Journal of the American Dietetic Association.

[99]  W. Zoller,et al.  [Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer]. , 2001, Zeitschrift fur Gastroenterologie.

[100]  J. Mecklin,et al.  Psychological consequences of predictive genetic testing for hereditary non‐polyposis colorectal cancer (HNPCC): A prospective follow‐up study , 2001, International journal of cancer.

[101]  T. Marteau,et al.  Genetic risk and behavioural change , 2001, BMJ : British Medical Journal.

[102]  S. Narod,et al.  Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. , 2000, American journal of human genetics.

[103]  Leif E. Peterson,et al.  Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: A Community-based study , 2000, Genetics in Medicine.

[104]  W. Foulkes,et al.  An evaluation of needs of female BRCA1and BRCA2 carriers undergoing genetic counselling , 2000, Journal of medical genetics.

[105]  M. Khoury,et al.  Contribution of different HFE genotypes to iron overload disease: a pooled analysis , 2000, Genetics in Medicine.

[106]  R. Croyle,et al.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. , 2000, Preventive medicine.

[107]  P. Devilee,et al.  Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation , 2000, The Lancet.

[108]  N. Caporaso,et al.  Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. , 1997, Addictive behaviors.

[109]  B. Bacon,et al.  Hereditary hemochromatosis: presentation and diagnosis in the 1990s. , 1997, The American journal of gastroenterology.

[110]  P. Reitsma,et al.  High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) , 1995, Blood.

[111]  B. Trock,et al.  Factors associated with repeat adherence to breast cancer screening. , 1990, Preventive medicine.

[112]  D. Miglioretti,et al.  Risk Factors for Breast Cancer for Women Aged 40 to 49 Years A Systematic Review and Meta-analysis , 2012 .

[113]  J. Kujovich.  Factor V Leiden thrombophilia , 2011, Genetics in Medicine.

[114]  S. Eichinger,et al.  Consequences of thrombophilia screening for life quality in women before prescription of oral contraceptives and family members of VTE patients. , 2009, Hamostaseologie.

[115]  M. Krause,et al.  A family with an interesting variant of Glanzmann‘s thrombasthenia , 2009, Hämostaseologie.

[116]  Brenda Wilson,et al.  A systematic review of perceived risks, psychological and behavioral impacts of genetic testing , 2008, Genetics in Medicine.

[117]  S. Narod,et al.  The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation , 2005, Familial Cancer.

[118]  J. Mecklin,et al.  Compliance and Satisfaction with Long-Term Surveillance in Finnish HNPCC Families , 2005, Familial Cancer.

[119]  I. Kirsch,et al.  Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[120]  F. Bray,et al.  Lung cancer in Europe in 2000: epidemiology, prevention, and early detection. , 2003, The Lancet. Oncology.

[121]  J. Saurin,et al.  Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[122]  B. Wilfond,et al.  Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. , 1997, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.